Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 10:50 PM UTC
| NCT Number | NCT06892522 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 602 participants |
| Active Locations | 14 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | July 21, 2026 (Jul 21, 2026) |
As of October 15, 2026: Clinical trial NCT06892522 is currently recruiting participants. This phase1 study for multiple myeloma is actively seeking new participants at 14 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06892522 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06892522 was last updated Jul 21, 2026 (July 21, 2026). HelloStudys verifies this status automatically.